Passività Correnti Cambiamento Data
Acadia Pharmaceuticals USD 332.22M 29.22M 2026-09
Agios Pharmaceuticals USD 77.59M 7.37M 2026-09
Akebia Therapeutics USD 162.35M 1.48M 2026-09
ALKERMES USD 651.93M 10.16M 2026-09
Alnylam Pharmaceuticals USD 2.06B 550.49M 2026-09
Amgen USD 23.23B 2.27B 2026-09
Biogen USD 3.9B 18.7M 2026-09
BioMarin Pharmaceutical USD 1.6B 59.17M 2026-09
Exelixis USD 411.88M 49.95M 2026-09
Immunic USD 31.55M 290K 2026-09
Incyte USD 1.44B 125.72M 2026-09
Ionis Pharmaceuticals USD 435.29M 119.65M 2026-09
MacroGenics USD 107.23M 1.58M 2026-09
Nektar Therapeutics USD 57.71M 4.17M 2026-03
Neurocrine Biosciences USD 984.6M 110.1M 2026-09
Prothena USD 11.43M 224K 2026-09
Regeneron Pharmaceuticals USD 6.2B 671.5M 2026-09
Ultragenyx Pharmaceutical USD 389M 38M 2026-09
Vertex Pharmaceuticals USD 5B 1.06B 2026-09